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Abstract
Cell Division is a new, open access, peer-reviewed online journal that publishes cutting-edge articles,
commentaries and reviews on all exciting aspects of cell cycle control in eukaryotes. A major goal
of this new journal is to publish timely and significant studies on the aberrations of the cell cycle
network that occur in cancer and other diseases.
Eukaryotic cells undergo cell division to produce two
daughter cells with a DNA content identical to the paren-
tal cell. This process is mediated by a complex, multimeric
machine composed of an effector protein-phosphoryla-
tion engine which is itself controlled and governed by a
regulatory protein network. Activation of the phosphor-
ylation engine by cyclin-dependent kinases (CDKs) drives
the transitions between the different phases of the cell
cycle. Various regulatory proteins provide a precise frame-
work for the regulation of CDK activities. The cell cycle
clock is turned on and off in response to mitogenic and
anti-mitogenic stimuli that initiate various signal trans-
duction events and ultimately impinge on the activity of
the CDKs. In addition, a network of surveillance mecha-
nisms or checkpoints is responsible for the correct order
and unidirectional nature of the cell cycle.
The Cell Cycle research field has matured and grown over
the past two decades, culminating in the 2001 Nobel Prize
awarded to Leland Hartwell, Tim Hunt and Paul Nurse.
The precise and accurate regulation of the cell cycle is
essential for cellular division in the context of normal
development. Alterations in cell cycle mechanisms have
been shown to contribute to unrestricted proliferation
and oncogenic transformation. A major challenge for the
field is a broader use of multiple model organisms in vivo.
This is in addition to the challenges of studying cell cycle
regulation in cell culture. Overcoming these challenges
will allow a deeper understanding of the cell cycle, help to
identify potential cancer targets, and promote the devel-
opment of novel strategies for cancer therapy.
In sum, the eukaryotic Cell Cycle field comprises a
number of related topics ranging from the signal transduc-
tion pathway to gene expression, from DNA replication to
DNA repair, and from checkpoints to finally cancer biol-
ogy.
The editorial board of Cell Division [1] includes 40 associ-
ate editors all of whom are leaders in the field of Cell
Cycle regulation [2]. As a logo for the journal, we have
chosen the MoebiusII strip. This logo represents a DNA
molecule folding upon itself and is meant to embody the
infinite and cyclic nature of life. We consider this logo to
be appropriate for a journal that aims at studying and
deciphering the mechanisms regulating the cycle that gen-
erates new cells.
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Cell Division [1] aims to be an open access, online forum
for and from the cell cycle community. The purpose of the
journal is to publish cutting-edge aspects of cell cycle
research and to bridge the gap between models of cell
cycle regulation and cancer biology. This forum will be
driven by the publication of specialized and timely
research articles, reviews, and commentaries focused on
this rapidly moving field–all meant to serve as invaluable
tools for cell cycle biologists. The journal will also con-
sider the following article types: book reviews, case
reports, hypotheses, methodology articles and short
reports.
To allow Cell Division to become a significant participant
in the Cell Cycle field, we encourage contributions of the
most groundbreaking, original and pioneering work from
your laboratories. In return, Cell Division will provide a
quick and impartial peer-review process. Accepted articles
will be published online immediately, which will be fol-
lowed by PubMed listing. To decide whether journal sub-
missions are worthy of in-depth peer-review, manuscripts
will be first examined by the Editors-in-Chief. Submis-
sions meeting the journal's standards will then result in
appropriate reviews being acquired. Based on reports and
scoring provided by the reviewers, the Editors-in-Chief
will make a final decision regarding acceptance of the
manuscripts. When submitting an article authors are
required to complete a declaration of competing interests.
Cell Division is published by BioMed Central. Hence, Bio-
Med Central member institutions will not incur Cell Divi-
sion publication charges, and BioMed Central supporter
member institutions pay a discounted publication charge.
BioMed Central is an independent publishing house com-
mitted to ensuring that peer-reviewed biomedical research
is open access and immediately and permanently availa-
ble online without charge or restrictions. The benefits pro-
vided by open access to science, medicine and the general
public are well documented [3], and we believe an open
access journal will be of great benefit to the Cell Cycle
field.
We invite you to work together with us to develop this
novel, high-visibility forum for the life sciences, the jour-
nal Cell Division.
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